bitop and Bausch Health extend their partnership and launch Ectoin® Allergy Nasal Spray in several European countries.
bitop and Bausch Health extend their partnership and launch Ectoin® Allergy Nasal Spray in several European countries.
Dortmund, March 16th 2021
We are very happy to announce that our partner Bausch Health Companies Inc. has launched Ectoin® Allergy Nasal Spray under their well-known and successful brands Vividrin® and Artelac® in South and Eastern European markets.
The Ectoin® Allergy Nasal Spray is a globally successful medical device for the treatment and prevention of allergic rhinitis symptoms. It protects against harmful influences of allergens and reduces allergen induced inflammations of the nasal mucosa. Containing the 100% natural cell-protective ingredient Ectoin®, the solution is membrane-stabilizing and has clinically shown to be as effective in reducing allergy symptoms as Azelastine - the pharmacological standard treatment.*
The Ectoin® Allergy Nasal Spray is a fitting line extension since Ectoin® containing Allergy Eye Drops have been distributed and established for many years in a high number of countries.
“After a well-established partnership in eye care we are happy to see the Ectoin® Allergy Nasal Spray under the strong brands of our long-term partner Bausch Health.”, states bitop CEO Wolfgang Hansen.
About Ectoin® containing OTC-products
For more than ten years, bitop has developed and registered medical devices with Ectoin® and out-licensed these patent-protected products in a full-service model to partners all over the world. The natural protection molecule Ectoin® is exclusively manufactured by bitop in Germany and provides a 100% natural mode of action. bitop offers Ectoin®- based health care products with clinically proven claims in the categories of Cough&Cold, Allergy, Pulmonary Diseases, Ophthalmology, Dermatology and Supportive Cancer Treatment.
For more information on the product range, please contact info@bitop.de or visit www.bitop.de or contact our sales team directly under bd@bitop.de
To read the full press release, please click here.
*Werkhäuser N, Bilstein A, Sonnemann U. Treatment of allergic rhinitis with ectoine containing nasal spray and eye drops in comparison with azelastine containing nasal spray and eye drops or with cromoglycic Acid containing nasal spray. J Allergy (Cairo). 2014; Epub.
